1973
DOI: 10.1016/0009-8981(73)90439-7
|View full text |Cite
|
Sign up to set email alerts
|

Enzymes of glutathione synthesis in patients with myeloproliferative disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
4
0

Year Published

1975
1975
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(6 citation statements)
references
References 10 publications
2
4
0
Order By: Relevance
“…Reduced glutathione levels were also increased in cancer tissues, consistent with previous research demonstrating that tripeptide levels were significantly elevated in tumor specimens [16–18] and in the blood cells of cancer patients [33,34]. Increased GSH concentration is a common characteristic of tumor cells; this may be related to the increase in GSH synthetase levels found in some tumor cell lines [35] and is responsible for the reduced sensitivity of cancer cells to chemotherapy and radiotherapy [36]. Increased GSH levels may reflect an adaptation against H 2 O 2 and other peroxides formed in tumor cells.…”
Section: Resultssupporting
confidence: 86%
“…Reduced glutathione levels were also increased in cancer tissues, consistent with previous research demonstrating that tripeptide levels were significantly elevated in tumor specimens [16–18] and in the blood cells of cancer patients [33,34]. Increased GSH concentration is a common characteristic of tumor cells; this may be related to the increase in GSH synthetase levels found in some tumor cell lines [35] and is responsible for the reduced sensitivity of cancer cells to chemotherapy and radiotherapy [36]. Increased GSH levels may reflect an adaptation against H 2 O 2 and other peroxides formed in tumor cells.…”
Section: Resultssupporting
confidence: 86%
“…The difference between the two means is statistically signifi- [7], was less than 3% of total GSH concentration in all samples. Despite the publication of a number of articles on the interactions between GSH and the efficacy of antineoplastic interventions [3,4], and the evidence of a deranged homeostasis of GSH in some solid tumors [2], hematologic neoplasms have not been thoroughly investigated in this respect, apart from an early report on elevation of GSH content and glutathione synthetase activity in the red cells of some patients with myeloproliferative disorders [8].…”
Section: Resultsmentioning
confidence: 99%
“…In some pathological conditions in which an abnormally high erythrocyte GSH level is a characteristic finding, the relative activities of the two enzymes show different patterns. Thus in iron deficiency anaemia both activities are higher than normal (Ramachandran & Iyer, 1980); in some myeloproliferative disorders only the GS activity is increased while the GCS activity is normal (Blume et al, 1973). It is obvious that the subject needs further investigation, In particular, the activities of these enzymes, estimated under conditions prevailing in the red-cell cytosol, may provide useful information on their role in maintaining the GSH concentration in health and disease.…”
Section: Discussionmentioning
confidence: 99%